201
Participants
Start Date
May 31, 2006
Primary Completion Date
January 31, 2007
Study Completion Date
December 31, 2007
Heat-Labile Enterotoxin of Escherichia coli (LT)
Subjects in Group 1 will receive two vaccinations of a patch containing 37.5µg LT 2 to 3 weeks apart.
Placebo
The placebo patch contains all of the components of the active patch, but with no LT included in the formulation.
Asthma Allergy & Associates, Ithica
Johns Hopkins University, Bloomberg School of Public Health, Baltimore
Private Clinic San Miguel, San Miguel de Allende
Radiant Research, Columbus
Private Clinic Guadalajara, Guadalajara
AmeriMed Hospital, Puerto Vallarta
Twin Cities Clinical Research, Minneapolis
Radiant Research, Chicago
Private Clinic Cuernavaca, Cuernavaca
Radiant Research, Dallas
Breco Research, Houston
Center for Infectious Diseases, The University of Texas Health Science Center at Houston, Houston
Hospital Americano, Cancún
Radiant Research, San Antonio
Jean Brown Research, Salt Lake City
West Coast Clinical Trials, Long Beach
Northwest Kinetics, Tacoma
Advanced Biomedical Research, Hackensack
Private Clinic Antigua, Antigua Guatemala
Intercell USA, Inc.
INDUSTRY